InvestSMART

Immuron Limited (ASX: IMC) - Announcements

- Current share price for IMC : $0.037

ASX company news and announcements for Immuron Limited (IMC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Immuron Limited (IMC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Immuron Limited (IMC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Immuron Limited (IMC)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$12 First Patients Enrolled in Campylobacter Clinical Study 4 Dec 2023 4:27PM $0.081 $0.037 fallen by 54.32%
$12 Investor Webinar Presentation 28 Nov 2023 4:13PM $0.084 $0.037 fallen by 55.95%
$12 Change of Director's Interest Notice (PB) 24 Nov 2023 1:55PM $0.076 $0.037 fallen by 51.32%
$12 Notification regarding unquoted securities - IMC 24 Nov 2023 1:46PM $0.076 $0.037 fallen by 51.32%
$12 Amended Constitution 22 Nov 2023 5:41PM $0.080 $0.037 fallen by 53.75%
$12 Results of Annual General Meeting 21 Nov 2023 12:15PM $0.080 $0.037 fallen by 53.75%
$12 Presentation to Annual General Meeting 21 Nov 2023 8:30AM $0.078 $0.037 fallen by 52.56%
$12 Investor Webinar Presentation 13 Nov 2023 8:56AM $0.075 $0.037 fallen by 50.67%
$12 Immuron CEO, Steven Lydeamore to present at AusBioInvest 30 Oct 2023 8:31AM $0.073 $0.037 fallen by 49.32%
$12 Notice of Annual General Meeting/Proxy Form 23 Oct 2023 10:11AM $0.076 $0.037 fallen by 51.32%
$12 Travelan Clinical Study Cohort 2 commences 18 Oct 2023 2:53PM $0.078 $0.037 fallen by 52.56%
$12 Immuron achieves record quarterly Travelan sales 11 Oct 2023 11:41AM $0.075 $0.037 fallen by 50.67%
$12 Immuron CEO, Steven Lydeamore to present at LD Micro 4 Oct 2023 9:06AM $0.082 $0.037 fallen by 54.88%
$12 Appendix 4G 28 Sep 2023 10:50AM $0.080 $0.037 fallen by 53.75%
$12 Corporate Governance Statement 28 Sep 2023 10:47AM $0.080 $0.037 fallen by 53.75%
$12 Annual Report to shareholders 28 Sep 2023 10:44AM $0.080 $0.037 fallen by 53.75%
$12 Immuron achieves record monthly Travelan sales 13 Sep 2023 11:32AM $0.073 $0.037 fallen by 49.32%
$12 Immuron CEO, Steven Lydeamore to present at H.C. Wainwright 11 Sep 2023 1:26PM $0.074 $0.037 fallen by 50%
$12 Appendix 4E Preliminary Final Report 30 Aug 2023 8:23AM $0.078 $0.037 fallen by 52.56%
$12 Immuron present to Military Health System Research Symposium 14 Aug 2023 9:35AM $0.080 $0.037 fallen by 53.75%
$12 Immuron Receives TGA GMP Clearance 9 Aug 2023 1:46PM $0.076 $0.037 fallen by 51.32%
$12 Immuron enrols patients in Travelan clinical study 25 Jul 2023 8:33AM $0.071 $0.037 fallen by 47.89%
$12 Immuron CEO, Steven Lydeamore to present at Bioshares 24 Jul 2023 9:13AM $0.076 $0.037 fallen by 51.32%
$12 Notification regarding unquoted securities - IMC 12 Jul 2023 5:02PM $0.078 $0.037 fallen by 52.56%
$12 Letter to Shareholders 11 Jul 2023 10:52AM $0.082 $0.037 fallen by 54.88%

201 - 225 of 790 results

Page 9 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.